Sanara MedTech (SMTI) Invested Capital (2016 - 2025)
Sanara MedTech's Invested Capital history spans 15 years, with the latest figure at $5.9 million for Q4 2025.
- For Q4 2025, Invested Capital fell 84.76% year-over-year to $5.9 million; the TTM value through Dec 2025 reached $5.9 million, down 84.76%, while the annual FY2025 figure was $5.9 million, 84.76% down from the prior year.
- Invested Capital reached $5.9 million in Q4 2025 per SMTI's latest filing, down from $6.1 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $54.3 million in Q4 2023 to a low of $5.9 million in Q4 2025.
- Average Invested Capital over 5 years is $36.4 million, with a median of $39.2 million recorded in 2024.
- Peak YoY movement for Invested Capital: skyrocketed 477.03% in 2021, then crashed 84.76% in 2025.
- A 5-year view of Invested Capital shows it stood at $30.2 million in 2021, then soared by 38.37% to $41.7 million in 2022, then soared by 30.24% to $54.3 million in 2023, then decreased by 28.39% to $38.9 million in 2024, then plummeted by 84.76% to $5.9 million in 2025.
- Per Business Quant, the three most recent readings for SMTI's Invested Capital are $5.9 million (Q4 2025), $6.1 million (Q3 2025), and $35.4 million (Q2 2025).